Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Indivior Inc.
This is a Phase IV, prospective, multicentre, multinational, open-label, real-world observational study in participants with current or a history of OUD/opioid dependence.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participants must meet all of the following criteria:
Is an adult ≥ 18 years of age who has signed the informed consent form
Plans to receive additional SUBLOCADE injections and
* Has initiated treatment for OUD/opioid dependence with SUBLOCADE within the last 3 months prior to Baseline Visit
* OR
* Has completed an Indivior SUBLOCADE study (eg, INDV-6000-401, INDV-6000-405) and has received the last dose of SUBLOCADE on that study within 3 months prior to Baseline Visit
Is not currently participating in any clinical trial requiring medical intervention
Is not currently using opioids to treat a diagnosis other than OUD/opioid dependence
